Review: Adjunctive Use of Cannabinoids Efficacious in Patients with Treatment-Resistant Epilepsy | NORML
SYDNEY, AUSTRALIA — The adjunctive use of cannabinoids, particularly CBD (cannabidiol), typically reduces seizure frequency and improves the quality of life in patients with intractable forms of epilepsy, according to a review of clinical data published in the Journal of Neurology, Neurosurgery & Psychiatry. Australian researchers reviewed data from six randomized, placebo-controlled studies, involving 555 patients, and from another 30 […]
Review: Adjunctive Use of Cannabinoids Efficacious in Patients with Treatment-Resistant Epilepsy | The Daily Chronic